REPICE, ANNA MARIA RITA
REPICE, ANNA MARIA RITA
SCIENZE NEUROLOGICHE E PSICHIATRICHE (attivo dal 01/08/1980 al 31/12/2012)
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet
2019 Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A.
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population.
2003 LIGUORI M; SAWCER S; SETAKIS E; COMPSTON A; GIORDANO M; D'ALFONSO S; MELLAI M; MALFERRARI G; TROJANO M; LIVREA P; DE ROBERTIS F; MASSACESI L; REPICE A; BALLERINI C; BIAGIOLI T; BOMPREZZI R; CANNONI S; RISTORI G; SALVETTI M; GRIMALDI L.M; BIUNNO I; COMI G; LEONE M; FERRO I; NALDI P; MILANESE C; GELLERA C; LOREDANA L.M; SAVETTIERI G; SALEMI G; ARIDON P; CAPUTO D; ROSA GUERINI F; FERRANTE P; MOMIGLIANO-RICHIARDI P;
Absence of association between intronic polymorphism in PS-1 gene and alzheimer's disease in italian patients
1997 Sorbi S.; Nacmias B.; Tedde A.; Repice A.M.; Forleo P.; Latorraca S.; Piacentini S.; Marcon G.; Amaducci L.
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.
2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
2022 Mariottini A, Repice AM, Barilaro A, Massacesi L
Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients
2010 Ballerini, C; Galante, A; Biagioli, T; Repice, A; Barilaro, A; Aldinucci, A; Massacesi, L
Association of celiac disease in patients with multiple sclerosis in Tuscany
2020 Piccini, Barbara; Ulivelli, Monica; Amato, Maria Pia; Bartalini, Sabina; Falcini, Mario; Giannini, Marta; Magnani, Eliana; Massacesi, Luca; Repice, Anna Maria; Vascotto, Marina; Grosso, Salvatore
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience
2012 Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R.
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis
2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis
2004 Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L
Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
2014 Massacesi L; Tramacere I; Amoroso S; Battaglia M; Benedetti MD; Filippini G; La Mantia L; Repice A M; Solari A; Tedeschi G; Milanese C
Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis
2004 Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L
Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions
2004 Repice, A; Barilaro, A; Parigi, A; Taiuti, B; Pellicano, G; Meucci, G; Fioretti, C; Valleriani, A; Onesti, E; Prosperini, L; Pozzilli, C; Massacesi, L
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume
2015 Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L
Case report: A multiple sclerosis patient with imaging features of glymphatic failure benefitted from CSF flow shunting
2022 Scollato, Antonio; Lolli, Francesco; Lastrucci, Giancarlo; Repice, Anna; De Santis, Giuseppe; Nicoletti, Claudio; Porfirio, Berardino; Gallina, Pasquale
Central vein sign differentiates MS from CNS inflammatory vasculopathies.
2018 Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L.
Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity
2009 Caleri, F; Repice, A; Zellini, F; Barilaro, A; De Cristofaro, MT; Pupi, A; Massacesi, L
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions
2021 Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study
2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY
2014 Di Gioia, M; Innocenti, C; Donnini, I; Nozzoli, C; Bosi, A; Guidi, S; Rigacci, L; Repice, A; Massacesi, L; Portaccio, E; Amato, MP; Saccardi, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet | 2019 | Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A. | |
| A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. | 2003 | LIGUORI M; SAWCER S; SETAKIS E; COMPSTON A; GIORDANO M; D'ALFONSO S; MELLAI M; MALFERRARI G; TROJANO M; LIVREA P; DE ROBERTIS F; MASSACESI L; REPICE A; BALLERINI C; BIAGIOLI T; BOMPREZZI R; CANNONI S; RISTORI G; SALVETTI M; GRIMALDI L.M; BIUNNO I; COMI G; LEONE M; FERRO I; NALDI P; MILANESE C; GELLERA C; LOREDANA L.M; SAVETTIERI G; SALEMI G; ARIDON P; CAPUTO D; ROSA GUERINI F; FERRANTE P; MOMIGLIANO-RICHIARDI P; | |
| Absence of association between intronic polymorphism in PS-1 gene and alzheimer's disease in italian patients | 1997 | Sorbi S.; Nacmias B.; Tedde A.; Repice A.M.; Forleo P.; Latorraca S.; Piacentini S.; Marcon G.; Amaducci L. | |
| Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. | 2017 | M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L. | |
| Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance | 2022 | Mariottini A, Repice AM, Barilaro A, Massacesi L | |
| Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients | 2010 | Ballerini, C; Galante, A; Biagioli, T; Repice, A; Barilaro, A; Aldinucci, A; Massacesi, L | |
| Association of celiac disease in patients with multiple sclerosis in Tuscany | 2020 | Piccini, Barbara; Ulivelli, Monica; Amato, Maria Pia; Bartalini, Sabina; Falcini, Mario; Giannini, Marta; Magnani, Eliana; Massacesi, Luca; Repice, Anna Maria; Vascotto, Marina; Grosso, Salvatore | |
| Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience | 2012 | Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R. | |
| Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis | 2022 | Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca | |
| Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis | 2004 | Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L | |
| Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial. | 2014 | Massacesi L; Tramacere I; Amoroso S; Battaglia M; Benedetti MD; Filippini G; La Mantia L; Repice A M; Solari A; Tedeschi G; Milanese C | |
| Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis | 2004 | Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L | |
| Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions | 2004 | Repice, A; Barilaro, A; Parigi, A; Taiuti, B; Pellicano, G; Meucci, G; Fioretti, C; Valleriani, A; Onesti, E; Prosperini, L; Pozzilli, C; Massacesi, L | |
| Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume | 2015 | Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L | |
| Case report: A multiple sclerosis patient with imaging features of glymphatic failure benefitted from CSF flow shunting | 2022 | Scollato, Antonio; Lolli, Francesco; Lastrucci, Giancarlo; Repice, Anna; De Santis, Giuseppe; Nicoletti, Claudio; Porfirio, Berardino; Gallina, Pasquale | |
| Central vein sign differentiates MS from CNS inflammatory vasculopathies. | 2018 | Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L. | |
| Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity | 2009 | Caleri, F; Repice, A; Zellini, F; Barilaro, A; De Cristofaro, MT; Pupi, A; Massacesi, L | |
| Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions | 2021 | Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi | |
| Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study | 2019 | Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM | |
| CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY | 2014 | Di Gioia, M; Innocenti, C; Donnini, I; Nozzoli, C; Bosi, A; Guidi, S; Rigacci, L; Repice, A; Massacesi, L; Portaccio, E; Amato, MP; Saccardi, R |